Meth-associated PAH care gaps: closing the divide
We know methamphetamine use is associated with pulmonary arterial hypertension (PAH), but this population's care needs haven't been studied. Dr. Anjali Vaidya and her team in the US interviewed patients with methamphetamine-associated PAH and presented a poster at the recent American Thoracic Society Conference.
They found that stigma affected clinical encounters for this very vulnerable population. Other critical issues included delayed diagnosis, insufficient patient education, and barriers to accessing PAH specialists, mental health supports, and substance use treatment.
Cat Water Fountain is a great resource for learning more about the work Dr. Vaidya is doing. It's really important to understand how stigma and delayed diagnosis create such significant barriers for this patient population. I hope this research helps lead to better, more integrated care pathways.
planliva does a great job highlighting how stigma impacts care for this group. It’s also important that the study points out the specific barriers, like the difficulty in accessing mental health and substance use treatment.
Reading planorial alongside this article gave me another way to think about Chat. The explanation of Chat was especially useful.
The page is set up for a direct chat, which is a simple way to handle contact. For a more structured contact form, you might want to try a grid maker.
This is a really clear explanation of how ToothfairyAI provides expert AI agents in Australia, helping businesses identify, plan, and implement intelligent AI solutions with confidence.